Renal agenesis, bilateral
Bilateral Renal Agenesis is a rare medical condition characterized by the absence of both kidneys at birth. This condition is a type of renal agenesis, which can also occur unilaterally (affecting only one kidney). Bilateral renal agenesis is a critical condition, as the kidneys play a crucial role in filtering waste products and excess fluids from the blood, which are then excreted in the urine.
Causes and Pathophysiology[edit]
The exact cause of bilateral renal agenesis is not fully understood, but it is believed to involve genetic and environmental factors. During fetal development, the kidneys form from the intermediate mesoderm. Disruption in the signaling pathways or genetic mutations can prevent the kidneys from developing. This condition is often associated with a range of other congenital anomalies, including issues with the lungs, heart, and urinary tract.
Diagnosis[edit]
Bilateral renal agenesis is typically diagnosed through prenatal ultrasound. The absence of kidneys and amniotic fluid (oligohydramnios) can indicate the condition. Oligohydramnios occurs because the fetus plays a significant role in producing amniotic fluid, primarily through urination. The lack of amniotic fluid can lead to further complications, including lung hypoplasia (underdeveloped lungs).
Prognosis[edit]
The prognosis for infants born with bilateral renal agenesis is poor. The condition is usually fatal shortly after birth due to the inability to remove waste products from the body and severe lung underdevelopment. There is currently no cure for bilateral renal agenesis, and treatment options are limited to supportive care.
Epidemiology[edit]
Bilateral renal agenesis is a rare condition. The exact incidence is difficult to determine but is estimated to occur in 1 in 3,000 to 4,000 pregnancies. The condition appears to affect males more frequently than females.
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
